Spectral AI, Inc. (MDAI)

Market Cap	31.64M
Revenue (ttm)	19.30M
Net Income (ttm)	-20.45M
Shares Out	17.48M
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	330,795
Open	1.980
Previous Close	1.950
Day's Range	1.760 - 1.990
52-Week Range	1.520 - 19.500
Beta	0.57
Analysts	Strong Buy
Price Target	4.00 (+120.99%)
Earnings Date	Aug 15, 2024

About MDAI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinici...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 78
• Stock Exchange: NASDAQ
• Ticker Symbol: MDAI

Financial Performance

In 2023, Spectral AI's revenue was $18.06 million, a decrease of -28.82% compared to the previous year's $25.37 million. Losses were -$20.85 million, 616.1% more than in 2022.

Analyst Forecast

According to one analyst, the rating for MDAI stock is "Strong Buy" and the 12-month stock price forecast is $4.0.

Price Target

$4.0

(120.99% upside)

Analyst Consensus: Strong Buy